Percutaneous ultrasound-guided renal biopsy in supine antero-lateral position: A new approach for obese and non-obese patients

Loreto Gesualdo, Luigi Cormio, Giovanni Stallone, Barbara Infante, Anna Maria Di Palma, Paolo Delli Carri, Mauro Cignarelli, Olga Lamacchia, Salvatore Iannaccone, Salvatore Di Paolo, Luigi Morrone, Filippo Aucella, Giuseppe Carrieri

Research output: Contribution to journalArticle

Abstract

Background. Percutaneous ultrasound (US)-guided renal biopsy is the gold standard in the evaluation of renal diseases, but some patients, such as the obese, may not be eligible for this procedure. Aim of this study was to determine the feasibility, efficacy and safety of US-guided percutaneous renal biopsy in supine antero-lateral position (SALP) in high-risk patients (BMI > 30 and/or respiratory difficulty), as well as to compare the overall outcome of SALP with that of traditional prone position (PP) in low-risk patients (BMI ≤ 30/no respiratory difficulty). Methods. One hundred and ten consecutive patients scheduled for native kidney biopsy were recruited. Ninety low-risk patients were randomized following a permuted block randomization list to receive either US-guided renal biopsy in PP (Group 1) or SALP (Group 2), whereas 20 high-risk patients received US-guided renal biopsy in SALP (Group 3) and were our observational cohort study. Comfort compliance and breathing difficulty in each group were evaluated by the Visual Analogue Scale (VAS). Bleeding complications were evaluated through US renal scanning. Results. Mean operating time was 7 min. Comfort compliance and breathing difficulty were significantly better for SALP in both low- and high-risk patients; there were no significant differences in pain after biopsy among the three groups. Bleeding complications were slightly higher in Group 1. Diagnostic yield was similar in all groups. Conclusions. SALP is reliable, minimally invasive, easy, highly successful, timesaving and almost free from severe side-effects. A better VAS score for breathing difficulty and comfort compliance characterizes this procedure, making it particularly suitable for obese patients.

Original languageEnglish
Pages (from-to)971-976
Number of pages6
JournalNephrology Dialysis Transplantation
Volume23
Issue number3
DOIs
Publication statusPublished - Mar 2008

Fingerprint

Kidney
Biopsy
Compliance
Prone Position
Respiration
Visual Analog Scale
Hemorrhage
Random Allocation
Observational Studies
Cohort Studies
Safety
Pain

Keywords

  • Biopsy complications
  • Obesity
  • Ultrasound percutaneous renal biopsy

ASJC Scopus subject areas

  • Nephrology
  • Transplantation
  • Medicine(all)

Cite this

Percutaneous ultrasound-guided renal biopsy in supine antero-lateral position : A new approach for obese and non-obese patients. / Gesualdo, Loreto; Cormio, Luigi; Stallone, Giovanni; Infante, Barbara; Palma, Anna Maria Di; Carri, Paolo Delli; Cignarelli, Mauro; Lamacchia, Olga; Iannaccone, Salvatore; Paolo, Salvatore Di; Morrone, Luigi; Aucella, Filippo; Carrieri, Giuseppe.

In: Nephrology Dialysis Transplantation, Vol. 23, No. 3, 03.2008, p. 971-976.

Research output: Contribution to journalArticle

Gesualdo, L, Cormio, L, Stallone, G, Infante, B, Palma, AMD, Carri, PD, Cignarelli, M, Lamacchia, O, Iannaccone, S, Paolo, SD, Morrone, L, Aucella, F & Carrieri, G 2008, 'Percutaneous ultrasound-guided renal biopsy in supine antero-lateral position: A new approach for obese and non-obese patients', Nephrology Dialysis Transplantation, vol. 23, no. 3, pp. 971-976. https://doi.org/10.1093/ndt/gfm669
Gesualdo, Loreto ; Cormio, Luigi ; Stallone, Giovanni ; Infante, Barbara ; Palma, Anna Maria Di ; Carri, Paolo Delli ; Cignarelli, Mauro ; Lamacchia, Olga ; Iannaccone, Salvatore ; Paolo, Salvatore Di ; Morrone, Luigi ; Aucella, Filippo ; Carrieri, Giuseppe. / Percutaneous ultrasound-guided renal biopsy in supine antero-lateral position : A new approach for obese and non-obese patients. In: Nephrology Dialysis Transplantation. 2008 ; Vol. 23, No. 3. pp. 971-976.
@article{35ed9b7f50d6447db4fd8c303970e6b0,
title = "Percutaneous ultrasound-guided renal biopsy in supine antero-lateral position: A new approach for obese and non-obese patients",
abstract = "Background. Percutaneous ultrasound (US)-guided renal biopsy is the gold standard in the evaluation of renal diseases, but some patients, such as the obese, may not be eligible for this procedure. Aim of this study was to determine the feasibility, efficacy and safety of US-guided percutaneous renal biopsy in supine antero-lateral position (SALP) in high-risk patients (BMI > 30 and/or respiratory difficulty), as well as to compare the overall outcome of SALP with that of traditional prone position (PP) in low-risk patients (BMI ≤ 30/no respiratory difficulty). Methods. One hundred and ten consecutive patients scheduled for native kidney biopsy were recruited. Ninety low-risk patients were randomized following a permuted block randomization list to receive either US-guided renal biopsy in PP (Group 1) or SALP (Group 2), whereas 20 high-risk patients received US-guided renal biopsy in SALP (Group 3) and were our observational cohort study. Comfort compliance and breathing difficulty in each group were evaluated by the Visual Analogue Scale (VAS). Bleeding complications were evaluated through US renal scanning. Results. Mean operating time was 7 min. Comfort compliance and breathing difficulty were significantly better for SALP in both low- and high-risk patients; there were no significant differences in pain after biopsy among the three groups. Bleeding complications were slightly higher in Group 1. Diagnostic yield was similar in all groups. Conclusions. SALP is reliable, minimally invasive, easy, highly successful, timesaving and almost free from severe side-effects. A better VAS score for breathing difficulty and comfort compliance characterizes this procedure, making it particularly suitable for obese patients.",
keywords = "Biopsy complications, Obesity, Ultrasound percutaneous renal biopsy",
author = "Loreto Gesualdo and Luigi Cormio and Giovanni Stallone and Barbara Infante and Palma, {Anna Maria Di} and Carri, {Paolo Delli} and Mauro Cignarelli and Olga Lamacchia and Salvatore Iannaccone and Paolo, {Salvatore Di} and Luigi Morrone and Filippo Aucella and Giuseppe Carrieri",
year = "2008",
month = "3",
doi = "10.1093/ndt/gfm669",
language = "English",
volume = "23",
pages = "971--976",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Percutaneous ultrasound-guided renal biopsy in supine antero-lateral position

T2 - A new approach for obese and non-obese patients

AU - Gesualdo, Loreto

AU - Cormio, Luigi

AU - Stallone, Giovanni

AU - Infante, Barbara

AU - Palma, Anna Maria Di

AU - Carri, Paolo Delli

AU - Cignarelli, Mauro

AU - Lamacchia, Olga

AU - Iannaccone, Salvatore

AU - Paolo, Salvatore Di

AU - Morrone, Luigi

AU - Aucella, Filippo

AU - Carrieri, Giuseppe

PY - 2008/3

Y1 - 2008/3

N2 - Background. Percutaneous ultrasound (US)-guided renal biopsy is the gold standard in the evaluation of renal diseases, but some patients, such as the obese, may not be eligible for this procedure. Aim of this study was to determine the feasibility, efficacy and safety of US-guided percutaneous renal biopsy in supine antero-lateral position (SALP) in high-risk patients (BMI > 30 and/or respiratory difficulty), as well as to compare the overall outcome of SALP with that of traditional prone position (PP) in low-risk patients (BMI ≤ 30/no respiratory difficulty). Methods. One hundred and ten consecutive patients scheduled for native kidney biopsy were recruited. Ninety low-risk patients were randomized following a permuted block randomization list to receive either US-guided renal biopsy in PP (Group 1) or SALP (Group 2), whereas 20 high-risk patients received US-guided renal biopsy in SALP (Group 3) and were our observational cohort study. Comfort compliance and breathing difficulty in each group were evaluated by the Visual Analogue Scale (VAS). Bleeding complications were evaluated through US renal scanning. Results. Mean operating time was 7 min. Comfort compliance and breathing difficulty were significantly better for SALP in both low- and high-risk patients; there were no significant differences in pain after biopsy among the three groups. Bleeding complications were slightly higher in Group 1. Diagnostic yield was similar in all groups. Conclusions. SALP is reliable, minimally invasive, easy, highly successful, timesaving and almost free from severe side-effects. A better VAS score for breathing difficulty and comfort compliance characterizes this procedure, making it particularly suitable for obese patients.

AB - Background. Percutaneous ultrasound (US)-guided renal biopsy is the gold standard in the evaluation of renal diseases, but some patients, such as the obese, may not be eligible for this procedure. Aim of this study was to determine the feasibility, efficacy and safety of US-guided percutaneous renal biopsy in supine antero-lateral position (SALP) in high-risk patients (BMI > 30 and/or respiratory difficulty), as well as to compare the overall outcome of SALP with that of traditional prone position (PP) in low-risk patients (BMI ≤ 30/no respiratory difficulty). Methods. One hundred and ten consecutive patients scheduled for native kidney biopsy were recruited. Ninety low-risk patients were randomized following a permuted block randomization list to receive either US-guided renal biopsy in PP (Group 1) or SALP (Group 2), whereas 20 high-risk patients received US-guided renal biopsy in SALP (Group 3) and were our observational cohort study. Comfort compliance and breathing difficulty in each group were evaluated by the Visual Analogue Scale (VAS). Bleeding complications were evaluated through US renal scanning. Results. Mean operating time was 7 min. Comfort compliance and breathing difficulty were significantly better for SALP in both low- and high-risk patients; there were no significant differences in pain after biopsy among the three groups. Bleeding complications were slightly higher in Group 1. Diagnostic yield was similar in all groups. Conclusions. SALP is reliable, minimally invasive, easy, highly successful, timesaving and almost free from severe side-effects. A better VAS score for breathing difficulty and comfort compliance characterizes this procedure, making it particularly suitable for obese patients.

KW - Biopsy complications

KW - Obesity

KW - Ultrasound percutaneous renal biopsy

UR - http://www.scopus.com/inward/record.url?scp=42449155564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42449155564&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfm669

DO - 10.1093/ndt/gfm669

M3 - Article

C2 - 17977877

AN - SCOPUS:42449155564

VL - 23

SP - 971

EP - 976

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 3

ER -